Pemryri Rtu
Payments companies reported to CMS as associated with Pemryri Rtu. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Pemryri Rtu, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Pemryri Rtu
These are the largest totals companies reported as associated with Pemryri Rtu. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Stephen Doggett | Newport Beach, CA | Radiation Oncology | $26.36 |
| Haresh Jhangiani | Fountain Valley, CA | $26.36 | |
| Ramesh Moolani | Chula Vista, CA | Hematology & Oncology | $24.56 |
| Stephen Makoni | Lake Worth, FL | Hematology & Oncology | $23.08 |
| Vaibhav Verma | Canfield, OH | Hematology & Oncology | $19.90 |
Prescribed Pemryri Rtu?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.